Pre-dispensing of antivirals to high-risk individuals in an influenza pandemic

Influenza and other Respiratory Viruses

Volumn 4, Issue 2, 2010, Pages 101-112

  Goldstein, Edward ^a   Miller, Joel C ^a,b   O'Hagan, Justin J ^a   Lipsitch, Marc ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Antivirals; High risk individuals; Influenza; Pre dispensing

Indexed keywords

ANTIVIRUS AGENT;

ANTIVIRAL THERAPY; ARTICLE; DISEASE COURSE; DISEASE SEVERITY; EARLY INTERVENTION; HEALTH CARE POLICY; HIGH RISK PATIENT; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLUENZA; INFLUENZA VIRUS A H1N1; MEDICAL DECISION MAKING; MORBID OBESITY; NEUROLOGIC DISEASE; PANDEMIC; PRE-DISPENSING OF ANTIVIRAL DRUG; PREGNANT WOMAN; PRESCRIPTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; RISK REDUCTION;

ANTIVIRAL AGENTS; CIVIL DEFENSE; DISEASE OUTBREAKS; HUMANS; INFLUENZA, HUMAN; MODELS, THEORETICAL;

EID: 77349089734     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2009.00128.x     Document Type: Article

References (30)

1. Aoki FY, Macleod MD, Paggiaro P. Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob Chemother 2003, 51:123-129.
2. Burch J, Corbett M, Stock C. Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis. Lancet Infect Dis 2009, 9:537-545.
3. McClellan K, Perry CM. Oseltamivir: a review of its use in influenza. Drugs. 2001, 61:263-283.
4. Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med 2003, 163:1667-1672.
5. Jain S, Kamimoto L, Bramley AM. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009, 361:1991-1993.
6. Janice KLouie, Meileen Acosta, Kathleen Winter. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009, 302:1896-1902. http://dx.doi.org/10.1001/jama.2009.1583, doi:
7. Study: Underlying conditions playing less of role in H1N1. http://www.cnn.com/2009/HEALTH/10/13/h1n1.preexisting.conditions/index.html, 13 October 2009. Available at: (Accessed 13 October 2009)
8. Jamieson DJ, Honein MA, Rasmussen SA. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet 2009, 374:451-458.
9. Influenza Pandemica (H1N1) 2009, http://www.redsalud.gov.cl/minsalaudios/reporte22octubre.pdf, Chile, Ministerio de Salud, Reporte 21 de Octubre de. Available at: (Accessed 22 October 2009)
10. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009, 361:680-689.
11. Rello J, Rodriguez A, Ibanez P. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Car 2009, 13:R148.
12. H1N1 leading to increased flu rates, more pediatric deaths. http://www.rwjf.org/publichealth/digest.jsp?id=23828, Available at:
13. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. http://www.cdc.gov/h1n1flu/recommendations.html, Available at: (Accessed 15 October 2009)
14. Use of antivirals to treat H1N1 flu virus. http://www.phac-aspc.gc.ca/alert-alerte/h1n1/antiviral-antiviraux05-01-eng.php, Available at: (Accessed 1 May 2009)
15. Prise en charge d'un cas de grippe A(H1N1) chez un adulte ou un enfant de plus de 40 kg. http://www.urml-alsace.fr/Portals/0/documentation_information/2009-07_M%C3%A9mo%20prise%20en%20charge%20adultes.pdf, Available at: (Accessed 6 August 2009)
16. Antiviral Medication Use - Treatment http://www.healthemergency.gov.au/internet/healthemergency/publishing.nsf/Content/clinical-antiviral, Australia, Department of Health and Ageing, Available at: (Accessed 1 October 2009)
17. Guidance on the Diagnosis and Management of Pandemic (H1N1) 2009 in the Pandemic 'Management' Phase, Version 3 http://www.moh.govt.nz/moh.nsf/pagesmh/9171/$File/diagnosis-and-mgmt-guidance-for-mgmt-phase-v3-30july09.doc, New Zealand, National Health Coordination Center, Available at: (Accessed 30 July 2009)
18. Toovey S, Rayner C, Prinssen E. Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review. Drug Saf 2008, 31:1097-1114. http://dx.doi.org/10.2165/0002018-200831120-00006, doi: Review. PubMed PMID: 19026027
19. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis 2002, 8:347-354.
20. Weekly pandemic flu media update. http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1254510639308, 22 October 2009. Available at: (Accessed 22 October 2009)
21. Lipsitch M, Cohen T, Murray M, Levin BR. Antiviral resistance and the control of pandemic influenza. PLoS Med 2007, 4:e15.
22. Wu JT, Leung GM, Lipsitch M, Cooper BS, Riley S. Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy. PLoS Med 2009, 6:e1000085. http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000085, Available at: (Accessed 19 May 2009)
23. Presanis AM, Lipsitch M, DeAngelis D. The severity of pandemic H1N1 influenza in the United States. http://knol.google.com/k/anne-m-presanis/the-severity-of-pandemic-h1n1-influenza/agr0htar1u6r/16#, April-July 2009. Available at: (Accessed 18 November 2009)
24. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.
25. A weekly influenza surveillance report prepared by the influenza division. http://www.cdc.gov/flu/weekly/, Available at: (Accessed 6 November 2009)
26. Keren R, Zaoutis TE, Bridges CB. Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA 2005, 294:2188-2194.
27. CDC reports 28 flu deaths among pregnant women. http://www.washingtonpost.com/wp-dyn/content/article/2009/10/01/AR2009100104308.html, 2 October 2009, Available at: (Accessed 2 October 2009)
28. Reinberg S. Swine flu poses risks to kids with neurological conditions. MedicineNet http://www.medicinenet.com/script/main/art.asp?articlekey=105290, Available at: (Accessed 2 September 2009)
29. Goldstein E, Lipsitch M. Antiviral usage for H1N1 treatment: pros, cons, and an argument for broader prescribing guidelines in the United States. PLOS Curr Influenza http://knol.google.com/k/edward-goldstein/antiviral-usage-for-h1n1-treatment-pros/1dfgb8wq76hv/2#, Available at: (Accessed at 11 November 2009)
30. Goldstein E, Miller JC, O'Hagan J, Lipsitch M. Predispensing of antivirals to high-risk individuals in an influenza pandemic. PLOS Curr Influenza 2009, http://knol.google.com/k/edward-goldstein/predispensing-of-antivirals-to-high/1uji2pldf66z5/1#, Available at: (Accessed 12 November 2009)